Form 4: Tenet Healthcare CFO Park Reports RSU Vesting, Tax Sales

Tenet Healthcare's EVP & CFO, Sun Park, reported the vesting of restricted stock units and subsequent tax-related share dispositions, alongside a new RSU grant.

Summary

• Sun Park, EVP & Chief Financial Officer of Tenet Healthcare Corp (THC), reported transactions related to common stock and restricted stock units.
• Park acquired 4,670 shares of common stock on February 27, 2026, resulting from the vesting of previously granted restricted stock units.
• Concurrently, Park disposed of 1,626 shares of common stock at $237.58 per share and 1,985 shares at $239.39 per share on February 27, 2026, to satisfy tax withholding obligations upon the vesting of performance share units and restricted stock units.
• Park was granted 7,520 new time-based restricted stock units on February 27, 2026, which will vest in one-third increments over the next three years.
• The second one-third increment of 4,670 2024 February Restricted Stock Units vested on February 27, 2026.
• Following these transactions, Park beneficially owns 19,438 shares of common stock directly, along with 7,520 new restricted stock units and 4,671 remaining unvested 2024 February restricted stock units.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event, reflecting ongoing executive equity compensation and alignment of interests, though tempered by routine tax-related share sales.

Positives

• The grant of 7,520 new restricted stock units aligns the EVP & CFO's interests with long-term shareholder value creation.
• The vesting of 4,670 restricted stock units demonstrates the realization of previously awarded equity compensation.

Negatives

• The disposition of 3,611 shares (1,626 + 1,985) to cover tax obligations reduces the direct common stock holdings of the EVP & CFO.

Future Outlook

The 7,520 new time-based restricted stock units granted on February 27, 2026, are scheduled to vest in one-third increments on the first, second, and third anniversaries of the grant date. The remaining 4,671 2024 February Restricted Stock Units will vest in a final one-third increment on the third anniversary of their grant date.

Industry Context

StockSavvy.ai notes this Form 4 details routine insider compensation and tax-related transactions, which are common across industries for executive compensation. The grant of new restricted stock units and the vesting of prior awards are standard mechanisms used by publicly traded companies like Tenet Healthcare to align executive incentives with long-term shareholder value and retain key talent.

Comparison to Industry Standards

• StockSavvy.ai observes that the compensation structure involving restricted stock units and subsequent tax-related share dispositions is a standard practice for executive compensation in publicly traded companies, aligning with typical industry benchmarks for incentivizing long-term performance.
• For example, similar RSU grant and vesting schedules are common at healthcare peers such as HCA Healthcare (HCA) and Universal Health Services (UHS), where executive equity compensation often includes multi-year vesting periods to promote sustained performance and retention.

Stakeholder Impact

• Shareholders: The grant of new restricted stock units aligns the EVP & CFO's long-term interests with shareholder value. The disposition of shares for tax purposes is a routine event and has minimal impact on overall share float.
• Employees: The equity compensation structure for the EVP & CFO may serve as a benchmark or example for other executive and key employee compensation plans.

Next Steps

• The first one-third increment of the 7,520 2026 February Restricted Stock Units will vest on the first anniversary of the grant date (February 27, 2027).
• Subsequent one-third increments of the 2026 February Restricted Stock Units will vest on the second and third anniversaries of the grant date.
• The final one-third increment of the 2024 February Restricted Stock Units will vest on the third anniversary of their grant date (February 28, 2027).

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, including the vesting of restricted stock units, tax-related share sales, and a new RSU grant. These are expected events and do not indicate any material change in the company's operational performance or strategic direction. As such, the filing provides no new information that would warrant a change in investment recommendation, leading to a 'hold' stance for seasoned investors.

Keywords

Tenet Healthcare, THC, Sun Park, EVP & CFO, Restricted Stock Units, RSU, Insider Trading, SEC Form 4, Equity Compensation, Stock Vesting, Share Disposition, Tax Withholding